Lab investigations | Total cases (No. = 280) | Test of significance | P value | ||
---|---|---|---|---|---|
Group I (No. = 140) | Group II (No. = 80) | Group III (No. = 60) | |||
Mean ± SD | Mean ± SD | Mean ± SD | |||
ALT (IU/ml) | 58.6 ± 7.8 | 75.0 ± 20.6 | 122.0 ± 66.4 | Kruskal-Wallis test = 17.6 | < 0.001** |
AST(IU/ml) | 44.1 ± 13.3 | 65.0 ± 23.3 | 114.2 ± 67.6 | Kruskal-Wallis test = 17.14 | < 0.001** |
ALP (IU/ml) | 29.8 ± 14.8 | 75.1 ± 24.4 | 134.8 ± 68.8 | Kruskal-Wallis test = 21.24 | < 0.001** |
GGT (IU/ml) | 12.7 ± 7.5 | 30.1 ± 10.8 | 63.3 ± 12.1 | Kruskal-Wallis test = 20.14 | < 0.001** |
Total bilirubin (mg/dl) | 1.1 ± 0.27 | 1.2 ± 0.84 | 1.8 ± 1.2 | Kruskal-Wallis test = 0.73 | 0.69 |
Albumin (g/dl) | 3.8 ± 0.54 | 3.7 ± 0.39 | 3.4 ± 0.37 | ANOVA test = 0.85 | 0.44 |
PT (s) | 14.5 ± 2.1 | 14.5 ± 1.6 | 14.9 ± 2.2 | ANOVA test = 0.08 | 0.92 |
PT concentration (%) | 86.3 ± 19.5 | 86.8 ± 9.5 | 84.9 ± 13.9 | ANOVA test = 0.05 | 0.95 |
INR | 1.2 ± 0.17 | 1.2 ± 0.15 | 1.2 ± 0.18 | ANOVA test = 0.09 | 0.91 |
Hb (gm/dl) | 13.6 ± 1.7 | 13.6 ± 1.3 | 12.8 ± 2.8 | ANOVA test = 0.41 | 0.67 |
PLT (X103/mm) | 186.2 ± 48.3 | 189.9 ± 57.4 | 157.0 ± 62.6 | Kruskal-Wallis test = 1.60 | 0.45 |
Glucose (mg/dl) | 92.9 ± 30.5 | 90.1 ± 25.6 | 98.2 ± 36.9 | Kruskal-Wallis test = 0.16 | 0.92 |
Creatinine(mg/dl) | 0.81 ± 0.12 | 0.81 ± 0.09 | 0.83 ± 0.13 | ANOVA test = 0.88 | 0.92 |
Urea (mg/dl) | 35.0 ± 10.9 | 44.5 ± 9.1 | 39.5 ± 11.3 | ANOVA test = 2.08 | 0.15 |